Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
GEN Restaurant Group, Inc. Announces First Quarter 2024 Financial Results
-
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
-
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
-
TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
-
Canoo Inc. Announces First Quarter 2024 Results
-
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
-
RYVYL Reports Q1 2024 Results
-
Bolt Biotherapeutics Reports First Quarter 2024 Results, Announces Strategic Pipeline Prioritization and Changes to Leadership Team
-
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance
-
Nasdaq Announces 2024 Annual Meeting of Shareholders
-
Rumble Reports First Quarter 2024 Results
-
Star Bulk Announces Date for the Release of First Quarter Ended March 31, 2024 Results, Conference Call and Webcast
-
CARGO Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
BioAtla Reports First Quarter 2024 Financial Results and Highlights Recent Progress
-
Vivos Therapeutics Reports First Quarter 2024 Financial Results and Provides Operational Update
-
Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
-
Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
-
Fiverr to Present at Upcoming Conference
-
Iridex Reports First Quarter 2024 Financial Results
-
Jones Soda Reports First Quarter 2024 Results
-
Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024
-
Definitive Healthcare to Present at the 52nd Annual J.P. Morgan Global Technology, Media and Communications Conference
-
Robinhood Markets, Inc. to Present at the J.P. Morgan Global Technology, Media and Communications Conference on May 21, 2024
-
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical device software for clinical decision support
-
Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results
-
Nyxoah Reports First Quarter 2024 Financial and Operating Results
-
BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
-
Eos Energy Enterprises Reports First Quarter 2024 Financial Results and Announces Successful Completion of Factory Acceptance Testing
-
Ardelyx, Inc. Reports Employment Inducement Grants
-
PepGen Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
-
Conifer Holdings Reports 2024 First Quarter Financial Results
-
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
-
SKYX Reports Record First Quarter Sales of $19.0 Million Compared to $18.6 Million for First Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart
-
Aptose Reports Results for the First Quarter 2024
-
TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
-
American Shared Hospital Services Reports First Quarter 2024 Financial Results
-
Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
-
OptimizeRx Reports First Quarter 2024 Financial Results
-
Capital Southwest Announces Financial Results for Fourth Fiscal Quarter and Fiscal Year Ended March 31, 2024 and Announces Total Dividends of $0.63 per share for the Quarter Ending June 30, 2024
-
Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer
-
Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Ba
-
CORRECTION - ES Bancshares, Inc. Announces First Quarter 2024 Results; Reports Organic Deposit Inflows, Reduces Wholesale Funding
-
TSS, Inc. Reports First Quarter 2024 Results
-
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Beam Therapeutics to Present Data Highlighting Robust Manufacturing Process for BEAM-101 at 2024 European Hematology Association (EHA) Hybrid Congress
-
Oxford Lane Capital Corp. Announces Increase in Monthly Common Stock Distributions and Announces Net Asset Value and Selected Financial Results for the Fourth Fiscal Quarter
-
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update


